(Q46404886)

21 December 2017

title

Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49. (English)

1 reference

21 December 2017

1 reference

Subhash C Chauhan

1

1 reference

21 December 2017

Maneesh Jain

2

1 reference

21 December 2017

Erik D Moore

3

1 reference

21 December 2017

Uwe A Wittel

4

1 reference

21 December 2017

Jing Li

5

1 reference

21 December 2017

Peter R Gwilt

6

1 reference

21 December 2017

David Colcher

7

1 reference

21 December 2017

Surinder K Batra

8

1 reference

21 December 2017

publication date

2 October 2004

1 reference

21 December 2017

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

21 December 2017

volume

32

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

264-273

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-004-1664-0

exact match

0 references

cites work

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct

1 reference

12 December 2020

Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.

1 reference

12 December 2020

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers

1 reference

12 December 2020

Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization

1 reference

12 December 2020

Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules

1 reference

12 December 2020

Recent progress in radioimmunotherapy for cancer

1 reference

12 December 2020

Use of monoclonal antibodies as radiopharmaceuticals for the localization of human carcinoma xenografts in athymic mice

1 reference

12 December 2020

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives

1 reference

12 December 2020

Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts

1 reference

12 December 2020

Clinical issues in antibody design.

1 reference

12 December 2020

Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49

1 reference

12 December 2020

Clinical evaluation of the new tumor marker TAG-72

1 reference

12 December 2020

Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies

1 reference

12 December 2020

Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion

1 reference

12 December 2020

Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.

1 reference

12 December 2020

Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli.

1 reference

12 December 2020

Antiidiotypic response against murine monoclonal antibodies reactive with tumor-associated antigen TAG-72

1 reference

12 December 2020

Pharmacokinetics and biodistribution of genetically engineered antibodies

1 reference

12 December 2020

Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study

1 reference

12 December 2020

In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates

1 reference

12 December 2020

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer

1 reference

12 December 2020

Synthesis of high avidity antibody fragments (scFv multimers) for cancer imaging

1 reference

12 December 2020

Tetravalent miniantibodies with high avidity assembling in Escherichia coli.

1 reference

12 December 2020

In vivo tumor targeting of a recombinant single-chain antigen-binding protein

1 reference

12 December 2020

Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody

1 reference

12 December 2020

Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate

1 reference

12 December 2020

Single-chain antigen-binding proteins

1 reference

12 December 2020

Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates

1 reference

12 December 2020

Generation and characterization of a single gene-encoded single-chain-tetravalent antitumor antibody

1 reference

12 December 2020

Effects of genetic engineering on the pharmacokinetics of antibodies.

1 reference

12 December 2020

Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer

1 reference

12 December 2020

Chelates and antibodies: current methods and new directions.

1 reference

12 December 2020

Generation of recombinant multimeric antibody fragments for tumor diagnosis and therapy.

1 reference

12 December 2020

Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application

1 reference

12 December 2020

Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.

1 reference

12 December 2020

10.1007/S00259-004-1664-0

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017